Vericel VCEL Insider Ownership

Updated Oct 10, 2026

In the last 12 months, insiders at Vericel made open-market sales of $7.89 million (201.31K shares) and bought no shares on the open market.

• Counted by insider, open-market selling of VCEL stock in the past 12 months came from 8 insiders, with no insider buying.
• Michael Halpin (Chief Operating Officer) sold the most Vericel stock on the open market over the past 12 months, $2.04 million (50.3K shares), most recently on August 3, 2026.
• Kevin F. McLaughlin (Director) made the most recent open-market trade by an insider of Vericel, a sale of 7K shares for $311,710 on August 12, 2026.
• Apart from open-market trades, VCEL insiders acquired 303.01K shares through option exercises and conversions and gave up 39.81K shares to cover taxes or exercise prices in the past 12 months.
• Business Quant data puts insider holdings in VCEL at 635.88K shares across insiders' latest Form 4 filings, or 1.24% of the 51.17Mn shares outstanding; that total is up 0.05% from 635.54K shares at the end of Q2 2026 and up 15.11% from 552.4K shares at the end of Q3 2025.
• Indirect holdings, through trusts, partnerships, family members and other entities, make up 2.57% (16.36K shares) of Vericel's insider total, with the other 97.43% (619.52K shares) held directly.
• VCEL's insider total is spread across 13 insiders who have filed a Form 4 in the past two years.
• Vericel's three biggest insider holders are Dominick Colangelo (President and CEO, 312.45K shares), Jonathan Mark Hopper (Chief Medical Officer, 75.75K shares) and Alan L. Rubino (Director, 64.19K shares), based on their latest Form 4 filings.
• Dominick Colangelo alone accounts for 49.14% of the shares held by Vericel insiders.
• Over the trailing 12 months, 12 insiders reported transactions in VCEL stock across 44 Form 4 filings.
• These insider figures for Vericel are based on Form 4 filings through August 14, 2026.